Pluristem Continues to Strengthen its Position in China and Receives Key Cell Therapy Patent
Nov 07, 2016 13:31 pm UTC| Business
Patent addresses methods of treating Ischemic conditions such as CLI using placental cells HAIFA, Israel, Nov. 07, 2016 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based...
Drone USA, Inc. Signs Letter of Intent to Acquire Accredited Aerospace Manufacturer and Distributor
Nov 07, 2016 13:31 pm UTC| Business
NEW YORK, Nov. 07, 2016 -- Drone USA, Inc. (OTC:DRUS) (“Drone USA” or the “Company”), a developer and manufacturer of low altitude Unmanned Aerial Vehicles (“UAV”) and related technologies, today announced that it has...
Nov 07, 2016 13:30 pm UTC| Business
DURHAM, N.C., Nov. 07, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...
Aqua Metals Provides Third Quarter 2016 Corporate Update
Nov 07, 2016 13:30 pm UTC| Business
ALAMEDA, Calif., Nov. 07, 2016 -- Aqua Metals, Inc. (NASDAQ:AQMS), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining™, has provided a corporate update and announced...
Nov 07, 2016 13:30 pm UTC| Business
MADISON, Wis., Nov. 07, 2016 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that management will host a teleconference and live...
First Horizon National Corp. to Post Analysts' Materials on www.FirstHorizon.com Nov. 7
Nov 07, 2016 13:30 pm UTC| Business
MEMPHIS, Tenn., Nov. 07, 2016 -- First Horizon National Corp. (NYSE:FHN) will post additional materials for equity analysts in the investor relations section of www.FirstHorizon.com today. First Horizon expects to...
Nov 07, 2016 13:30 pm UTC| Business
-- Oral presentation at the American Society of Nephrology (ASN) Kidney Week 2016 to highlight Phase II AAV CLEAR trial results -- -- Oral presentation at the American College of Rheumatology (ACR) 2016 Annual Meeting to...